Alex Berks Recording of Integrative Oncology Talk

 Please follow the link to here a talk by Alex Berks on Integrative Oncology to the West Los Angeles Cancer Support Community on June 7, 2011.




Click here to download the Powerpoint slides.  This can be found under the HTTP link on the left

How Chronic Stress Reprograms Immune Cells to Facilitate Cancer Progression

(HealthNewsDigest.com) - Chronic stress acts as a sort of fertilizer that feeds breast cancer progression, significantly accelerating the spread of disease in animal models, researchers at UCLA’s Jonsson Comprehensive Cancer Center have found.

Researchers discovered that stress is biologically reprogramming the immune cells that are trying to fight the cancer, transforming them instead from soldiers protecting the body against disease into aiders and abettors. The study found a 30-fold increase in cancer spread throughout the bodies of stressed mice compared to those that were not stressed.

It’s long been thought that stress fuels cancer growth in humans. This study provides a model that not only demonstrates that stress can speed up cancer progression, but also details the pathway used to change the biology of immune cells that inadvertently promote the spread of cancer to distant organs, where it is much harder to treat.

The study appears in the Sept. 15, 2010 issue of the peer-reviewed journal Cancer Research.

“What we showed for the first time is that chronic stress causes cancer cells to escape from the primary tumor and colonize distant organs,” said Erica Sloan, a Jonsson Cancer Center scientist, first author of the study and a researcher with the Cousins Center for Psychoneuroimmunology. “We not only showed that this happens, but we showed how stress talks to the tumor and helps it to spread.”

In addition to documenting the effects of stress on cancer metastasis, the researchers were also able to block those effects by treating stressed animals with drugs that block the nervous system’s reprogramming of the metastasis-promoting immune cells, called macrophages.

Beta blockers, used in this study to shut down the stress pathways in the mice, are currently being examined in several large breast cancer databases for their role in potential prevention of recurrence and cancer spread, said Dr. Patricia Ganz, director of cancer prevention and control research at UCLA’s Jonsson Comprehensive Cancer Center. If preliminary findings indicate benefit, early phase clinical trials are being considered at the Jonsson Cancer Center testing beta blockers as a means of preventing breast cancer recurrence. Other healthy lifestyle behaviors may also influence the biological pathways described in the study, such as exercise and stress reduction techniques.

“We’re going to be focusing on younger women, because they may have a multitude of things weighing on them when they’re diagnosed with breast cancer. Younger women have more significant life demands and typically are under more stress,” Ganz said.

Ganz said her proposed research will focus on “host factors,” or things affecting the patient, that may be aiding the cancer progression and could help explain why a group of patients with the same type and stage of disease have varying rates of recurrence and cancer spread.

“This study provides evidence for a biological relationship between stress and cancer progression and identifies targets for intervention in the host environment,” Ganz said. “Because of this study, we may be able to say to a patient in the future that if you follow this exercise regimen, meditative practice or take this pill every day it will help prevent recurrence of your cancer. We can now test these potential interventions in the animal model and move those that are effective into the clinic.”

In Sloan’s study, mice with breast cancer were divided into two groups. One group of mice was confined in a small area for a short period of time every day for two weeks, while the other group was not. The breast cancer cells were genetically engineered to include the luciferase gene, which is the molecule that makes a firefly glow. The growth and spread of the cancer in the mice was monitored using sensitive cameras that can pick up the luciferase signal and allowed Sloan and her team to observe both the development of primary tumors and the spread of metastases throughout the body, said Steven Cole, an associate professor of hematology/oncology, a Jonsson Cancer Center researcher and senior author of the study.

What was interesting, Cole said, was that the primary tumors did not seem to be affected by stress and grew similarly in both groups of mice. However, the stressed animals showed significantly more metastases throughout the body than did the control group. The cancer, in effect, acted differently in the stressed mice.

“This study is not saying that stress causes cancer, but it does show that stress can help support cancer once it has developed,” Cole said. “Stress helps the cancer climb over the fence and get out into the big, wide world of the rest of the body.”

Cole said Sloan detailed the biology of the stress-induced changes in the cancer cells along every step of the pathway, providing a road map by which stress promotes cancer metastasis. Additionally, she proved that using beta blockers in stressed mice prevented the same cancer progression seen in the stressed mice that did not receive medication.

When cancer occurs, the immune system sends out macrophages to try to repair the tissue damage caused by uncontrolled growth of cancer cells. The macrophages, in an attempt to help, turn on inflammation genes that are part of the normal immune response to injury. However, the cancer cells feed on the growth factors involved in a normal immune response. Blood vessels that are grown to aid healing instead feed the cancer the oxygen and nutrients it needs to grow and spread, and the extra cellular matrix, which provides structural support for normal cells, is attacked during the immune response, In Sloan’s study, mice with breast cancer were divided into two groups. One group of mice was confined in a small area for a short period of time every day for two weeks, while the other group was not. helping the cancer cells escape from the primary tumor and spread to distant parts of the body.

“Many of the genes that promote cancer metastasis get turned on during the immune response by macrophages,” Cole said. “This study shows that stress signaling from the sympathetic nervous system enhances the recruitment of macrophages into the primary tumor, and increases their expression of immune response genes that inadvertently facilitate the escape of cancer cells into other parts of the body.”

Sloan showed that the beta blockers prevented the macrophages from hearing the signals sent by the sympathetic nervous system, and stopped them from infiltrating the tumor and encouraging cancer spread.

The study was funded by the National Institutes of Health, the Department of Defense and the Jonsson Cancer Center.

UCLA's Jonsson Comprehensive Cancer Center has more than 240 researchers and clinicians engaged in disease research, prevention, detection, control, treatment and education. One of the nation's largest comprehensive cancer centers, the Jonsson center is dedicated to promoting research and translating basic science into leading-edge clinical studies. In July 2010, the Jonsson Cancer Center was named among the top 10 cancer centers nationwide by U.S. News & World Report, a ranking it has held for 10 of the last 11 years. For more information on the Jonsson Cancer Center, visit our website at http://www.cancer.ucla.edu.

N-acetyl-cysteine (NAC): good for some things but dangerous with cancer.

High grade soft tissue sarcomas in one study exhibit high levels of glutathione, especially after Doxirubicin therapy.  This is my situation exactly.  Link to the study here. 

The article below comes from Jacob Schor a Naturopath specializing in cancer.  

NAC is the precursor to a chemical called glutathione.  Oral NAC is rapidly taken up by the body and quickly converted to glutathione.

Glutathione is the primary antioxidant within all of our cells.  It protects our cells from oxidative damage.  This is a good thing in healthy cells; we prefer that they are not damaged.  But in cancer cells we prefer the opposite.  We want cancer cells to be extra vulnerable to damage.  Cancer cells generate oxidative chemicals referred to in total as reactive oxygen species (ROS) in an attempt to destroy themselves.  Glutathione acts as a brake and prevents them from self-destruction or to use the scientific term, apoptosis. 

Raising glutathione stops cancer cell death. 

Most cancer therapies work to kill cancer cells by increasing the levels of reactive oxygen species within the cancer cells.  This includes radiation therapy, most chemotherapies and most natural therapies. 

Providing cancer cells with NAC, because it will increase glutathione, protects the cancer cells and prevents them from dying. 

We often see NAC being used in studies investigating the mechanisms of how anticancer agents work; they use NAC in a simple trick to see if the drugs are killing cancer cells through the common mechanism of increasing reactive oxygen species.  If adding NAC stops the action of the anticancer agent, than it is assumed it was acting through oxidative action.  Let me find a recent example.

In April 2010, Korean researchers reported on the action of NAC in combination with a proteosome inhibiting chemotherapy drug known as MG132.

 First they showed that MG132 increased the amounts of ROS in lung cancer cells and as expected, the drug slowed the rate of growth of the cancer cells. Then they treated the cancer cells with NAC.  The drug no longer slowed growth rates.  

The procedures followed in this study were not novel. They are routine when evaluating chemotherapy drugs.  First, measure how well the drug works against tumor cells and then measure whether NAC stops the effect.  This tells the scientists to what degree the drug’s action is via reactive oxygen species generation and whether other anti-cancer mechanisms are involved.

It’s not just the medical treatments that NAC will potentially interfere with.  A paper from December 2010 tells us that NAC ‘blocked the antiproliferative’ effect of curcumin, that is stopped it from hindering the growth of cancer cells. 

For the whole story click on the title to follow the link.

'I'm a tumor and I'm over here!' Nanovaults used to prod immune system to fight cancer

By Kim Irwin and Jennifer Marcus May 03, 2011

Nanovaults

UCLA scientists have discovered a way to "wake up" the immune system to fight cancer by delivering an immune system–stimulating protein in a nanoscale container called a vault directly into lung cancer tumors. The new method harnesses the body's natural defenses to fight disease growth.

The vaults, barrel-shaped nanoscale capsules found in the cytoplasm of all mammalian cells, were engineered to slowly release a protein — the chemokine CCL21 — into tumors. Pre-clinical studies in mice with lung cancer showed that the protein stimulated the immune system to recognize and attack cancer cells, potently inhibiting cancer growth, according to the study's co-senior author Leonard Rome, a researcher at UCLA's Jonsson Comprehensive Cancer Center and associate director of the California NanoSystems Institute (CNSI) at UCLA.

"Researchers have been working for many years to develop effective immune therapies to treat cancer, with limited success," said Rome, who has been studying vaults for decades. "In lung tumors, the immune system is down-regulated, and what we wanted to do was wake it up, find a way to have the cancer say to the immune system, 'Hey, I'm a tumor and I'm over here. Come get me.' "

The study appears in the May 3 issue of PLoS One, a peer-reviewed journal of the Public Library of Science.

Waking up the immune system

The new vault delivery system, which Rome characterized as "just a dream" three years ago, is based on a 10-year, ongoing research effort focused on using a patient's white blood cells to create dendritic cells, which are immune system cells that process antigen material and present it on their surface to other immune cells known as T cells, stimulating a response. 

Interview With Alternative Cancer Doctor Nicholas Gonzalez

This is an interview of noted cancer specialist Nicholas Gonzalez by Joseph Mercola.  Dr. Gonzalez uses a system of metabolic typing diets, juicing, coffee enemas to detox colon and liver and very high doses of pancreatic enzymes.  The history of the development of this story is fascinating.  

Dr. Mercola's Comments:

Alternative cancer treatments are a kind of "forbidden area" in medicine, but Dr. Gonzalez chose to go that route anyway, and has some remarkable success stories to show for his pioneering work.
He didn't set out to treat cancer at first however, let alone treat patients. His original plan was to be a basic science researcher at Sloan-Kettering; a teaching hospital for Cornell Medical College. He had a chance meeting with William Kelley, a controversial dentist who was one of the founders of nutritional typing. Dr. Kelley had been practicing alternative- and nutritional approaches for over two decades at the time, led him to begin a student project investigation of Kelley's work, in the summer of 1981.

"I started going through his records and even though I was just a second year medical student, I could see right away there were cases that were extraordinary," he says. "Patients with appropriately diagnosed pancreatic cancer, metastatic breast cancer in the bone, metastatic colorectal cancer… who were alive 5, 10, 15 years later under Kelley's care with a nutritional approach."

This preliminary review led to a formal research study, which Dr. Gonzalez completed while doing his fellowship in cancer, immunology and bone marrow transplantation.

The "Impossible" Recoveries of Dr. Kelley's Cancer Patients

After going through thousands of Kelley's records, Dr. Gonzalez put together a monograph, divided into three sections:

1. Kelley’s theory
2. 50 cases of appropriately-diagnosed lethal cancer patients still alive five to 15 years after diagnosis, whose long-term survival was attributed to Kelley’s program
3. Patients Kelley had treated with pancreatic cancer between the years 1974 and 1982

According to Dr. Good, the president of Sloan-Kettering who had become Gonzalez' mentor, if Kelley could produce even one patient with appropriately diagnosed pancreatic cancer who was alive 5-10 years later, it would be remarkable. They ultimately tracked down 22 of Kelley's cases. Ten of them met him once and didn't do the program after being dissuaded by family members or doctors who thought Kelley was a quack.
The average survival for that group was about 60 days.
A second group of seven patients who did the therapy partially and incompletely (again, dissuaded by well-intentioned but misguided family members or doctors), had an average survival of 300 days.
The third group consisting of five patients, who were appropriately diagnosed with advanced pancreatic cancer and who completed the full program, had an average survival of eight and a half years! In Dr. Gonzalez' words, this was "just unheard of in medicine."
One of those patients included a woman diagnosed by the Mayo Clinic with stage four pancreatic cancer who had been given six months to live. She'd learned about Kelley's program through a local health food store. She completed his treatment and is still alive today, 29 years later.

Total Video Length: 1:42:22
Download Interview Transcript

In looking around the internet I found a clinic that gives a basic rundown of what Dr. Gonzalez is doing.
http://www.aspenintegrativemedicine.com/?q=node/49

Dr. Kelley's original book is online here
http://www.drkelley.com/CANLIVER55.html







 

Meats Not To Eat

You might have missed the media headlines last month which extolled hotdogs as better for you than chicken. If you click on the Time Magazine link above you can get a taste of this nonsense. This is a perfect example of how taking too narrow-minded a view can lead you astray from the truth about what's healthy and what's not.
Here, the researchers measured several different types of meats for levels of heterocyclic amines (HCAs), and because hot dogs and pepperoni happened to have lower levels of HCAs than rotisserie chicken, MSNBC leapt to the conclusion that these processed meats are better for you because they're "relatively free of carcinogenic compounds."
WRONG! They're just relatively lower in ONE type of carcinogenic compound! But hot dogs and other processed meats contain OTHER compounds that put them squarely on the list of foods to avoid or eliminate entirely...

Researchers Create Better Ways to Spot Cancer Cells

Cancer can be notoriously difficult to spot, so scientists are working to develop new techniques to better detect tumors in the body. Such tools could potentially identify cancer cells more reliably and earlier than currently available methods, such as mammography, biopsies and magnetic resonance imaging, or MRI. Improved detection methods could help speed up treatment decisions and monitor whether a therapy is working.

The Root Cause of Cancer Almost Universally Ignored by Doctors...

In 1971 President Nixon and Congress declared war on cancer. So what's happened in the 40 years since? After weeding out the hype and filling in the actual statistics, it turns out, not much.

"These summary statistics show that the war on cancer has not gone well," says the article's author, Reynold Spector. "This is in marked contrast to death rates from stroke and cardiovascular disease (adjusted for the age and size of the population), which have fallen by 74 percent and 64 percent, respectively, from 1950 through 2006; and by 60 percent and 52 percent, respectively, from 1975 through 2006 (Kolata 2009a).
Cancer therapy is clearly decades behind."

Further down the article.  Dr. Mercola writes:  

Getting to the Root of the Problem

I strongly believe the cancer rates are escalating because they are in no way shape or form addressing the underlying cause of most cancers. Instead, most of the research is directed towards expensive drugs that target late stages of the disease and greatly enrich the drug companies but simply do not prevent cancer.
If ever there was an area in which an ounce of prevention is worth a pound of cure it is cancer. I strongly believe that if you are able to work your way up to the advanced health plan, that you will virtually eliminate the risk of most cancers.
Environmental- and lifestyle factors are increasingly being pinpointed as the primary culprits fueling our cancer epidemic.

 

Association of Integrative Oncology and Chinese Medicine

I and colleagues from many parts of the world are interested in creating a Society of Chinese Medicine practitioners interested in Integrative Oncology.  The endeavor to bring this Society to life is about creating community, and organizing standards and competencies and then teaching to those standards. 

For more information about the AIOCM click here. 

Mechanism for Link Between High Fat Diet and Risk of Prostate Cancer and Disorders Unveiled

ScienceDaily (July 16, 2010) — Prostate cancer is the second leading cause of cancer-related deaths in men with an estimated 192,280 new cases diagnosed in the US in 2009. Diet is considered one of the most important controllable risk factors for inflammation and prostate diseases including benign prostatic hyperplasia (BPH), prostatitis, and prostate cancer.

Sanjay Gupta, MS, PhD, Carter Kissell associate professor & research director in the Department of Urology and associate professor in the Department of Nutrition in the Case Western Reserve School of Medicine, and his team of post-doctoral fellows have focused on understanding the mechanisms of the deleterious effects of a high fat diet on the prostate. Previously, Dr. Gupta's team demonstrated that nuclear factor kappa B (NF-κB), a protein complex that controls DNA transcription which is activated as a result of inflammation and stress, is constitutively activate in human prostate adenocarcinoma and is related to tumor progression (Shukla S et al, Neoplasia, 2004).
In a new study published in the journal The Prostate, Dr. Gupta and his team demonstrate that a high fat diet results in activation of NF-κB in the abdominal cavity, thymus, spleen, and prostate. Non-obese NF-κB reporter mice were fed a high fat diet for four, eight, and 12 weeks. Compared with mice fed a regular diet, the high fat diet group had significant increases in prostate weight, and in the prostate expression of markers of oxidative stress (such as NADPH), and inflammation (such as the downstream targets of NF-κB: nitric oxide synthase, and cyclooxygenase [COX-2]) were increased. These studies provide direct evidence that a high fat diet causes proliferation, inflammation, and oxidative stress that can lead to benign prostatic hyperplasia, prostatitis, and cancer of the prostate, some of the most common disorders affecting adult men.
"Our studies provide evidence that a high-fat diet increases the activation of NF-κB along with elevated levels of NADPH oxidase components which might lead to intraprostatic inflammation. This study strengthens the link between a high-fat diet -- typical of "Western style" high fat diet -- as a potential cause of prostatic diseases including BPG and prostate cancer," said Dr. Gupta.
This work was supported by grants from the National Cancer Institute, the National Center for Complementary and Alternative Medicine, and the Sullivan Foundation for the Study of Prostatitis.

Alex's note:  There are plenty of natural products to control NF-κB